The women's health startup will use a Catalio-led Series B to turn vaginal microbiome data into fertility and diagnostic tools.
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.
Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
The agentic AI coding platform says the round, led by Define Ventures, brings its total funding to $51 million.
A Bessemer-led $50M round backs Flagler Health's AI-native operating platform for musculoskeletal care.
Aureka closes a $100M Series B to train biological foundation models for AI-driven drug discovery.
Israeli startup QuantHealth raises $45M to scale AI-powered clinical trial simulations.